Evidence map›Paper›PMID 34311674›Full record

ArticleEpigenetics2022

DNA methylome in visceral adipose tissue can discriminate patients with and without colorectal cancer.

Andrea G Izquierdo, Hatim Boughanem, Angel Diaz-Lagares, Isabel Arranz-Salas, Manel Esteller, Francisco J Tinahones, Felipe F Casanueva, Manuel Macias-Gonzalez, Ana B Crujeiras

Open access · bronzeAbstract read
In one paragraph

Article in Epigenetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. PRDM Proteins Orchestrate Colorectal Cancer Tumorigenesis.International journal of molecular sciences · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. UnravelingInternational journal of molecular sciences · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Andrea G IzquierdoEpigenomics in Endocrinology and Nutrition Group, Epigenomics Unit, Instituto De Investigacion Sanitaria De Santiago De Compostela (IDIS), Complejo Hospitalario Universitario De Santiago De Compostela (CHUS/SERGAS), and Centro De Investigacion Biomedica En Red Fisiopatologia De La Obesidad Y Nutricion (Ciberobn), Spain.ORCID 0000-0002-0846-8834
Hatim BoughanemDepartment of Endocrinology and Nutrition, Virgen De La Victoria University Hospital, University of Malaga (IBIMA), Spain and Centro De Investigacion Biomedica En Red Physiopathology of Obesity and Nutrition (Ciberobn), Málaga, Spain.ORCID 0000-0001-7743-311X
Angel Diaz-LagaresCancer Epigenetics, Translational Medical Oncology (Oncomet), Instituto De Investigacion Sanitaria De Santiago De Compostela (IDIS), Complejo Hospitalario Universitario De Santiago De Compostela (CHUS/SERGAS), and Centro De Investigacion Biomedica En Red Oncología (CIBERONC), Spain.ORCID 0000-0002-9114-9227
Isabel Arranz-SalasUnit of Anatomical Pathology, Virgen de la Victoria University Hospital, Málaga, Spain.ORCID 0000-0003-3603-9516
Manel EstellerJosep Carreras Leukemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Centro De Investigacion Biomedica En Red Oncologia (CIBERONC), Madrid, Spain; Institucio Catalana De Recerca I Estudis Avançats (ICREA), Barcelona, Catalonia, Spain; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain.ORCID 0000-0003-4490-6093
Francisco J TinahonesDepartment of Endocrinology and Nutrition, Virgen De La Victoria University Hospital, University of Malaga (IBIMA), Spain and Centro De Investigacion Biomedica En Red Physiopathology of Obesity and Nutrition (Ciberobn), Málaga, Spain.ORCID 0000-0001-6871-4403
Felipe F CasanuevaMolecular and Cellular Endocrinology Group. Instituto De Investigacion Sanitaria De Santiago De Compostela (IDIS), Complejo Hospitalario Universitario De Santiago De Compostela (CHUS), Santiago De Compostela University (USC) and Centro De Investigacion Biomedica En Red Fisiopatologia De La Obesidad Y Nutricion (Ciberobn), Spain.ORCID 0000-0002-9052-8161
Manuel Macias-GonzalezDepartment of Endocrinology and Nutrition, Virgen De La Victoria University Hospital, University of Malaga (IBIMA), Spain and Centro De Investigacion Biomedica En Red Physiopathology of Obesity and Nutrition (Ciberobn), Málaga, Spain.ORCID 0000-0002-6475-4704
Ana B CrujeirasEpigenomics in Endocrinology and Nutrition Group, Epigenomics Unit, Instituto De Investigacion Sanitaria De Santiago De Compostela (IDIS), Complejo Hospitalario Universitario De Santiago De Compostela (CHUS/SERGAS), and Centro De Investigacion Biomedica En Red Fisiopatologia De La Obesidad Y Nutricion (Ciberobn), Spain.ORCID 0000-0003-4392-0301
Instituto de Investigación Sanitaria de Santiago · ESSpanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition · ESHospital Clínico Universitario Virgen de la Victoria · ESInstitució Catalana de Recerca i Estudis Avançats · ESServicio Gallego de Salud · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adipose tissue dysfunction, particularly the visceral (VAT) compartment, has been proposed to play a relevant role in colorectal cancer (CRC) development and progression. Epigenetic mechanisms could be involved in this association. The current study aimed to evaluate if specific epigenetic marks in VAT are associated with colorectal cancer (CRC) to identify epigenetic hallmarks of adipose tissue-related CRC. Epigenome-wide DNA methylation was evaluated in VAT from 25 healthy participants and 29 CRC patients, using the Infinium HumanMethylation450K BeadChip. The epigenome-wide methylation analysis identified 170,184 sites able to perfectly separate the CRC and healthy samples. The differentially methylated CpG sites (DMCpGs) showed a global trend for increased methylated levels in CRC with respect to healthy group. Most of the genes encoded by the DMCpGs belonged to metabolic pathways and cell cycle, insulin resistance, and adipocytokine signalling, as well as tumoural transformation processes. In gene-specific analyses, involved genes biologically relevant for the development of CRC include

Indexed as

Colorectal NeoplasmsIntra-Abdominal FatAdipose TissueCpG IslandsDNA MethylationEpigenesis, GeneticEpigenomeHumansMicrotubule-Associated ProteinsMicrotubule-Associated ProteinsTBCD protein, humanadipose tissuecancerDNA methylationmicroarrayobesity

Identifiers

PMID34311674
PMCPMC9235880
OpenAlexW3186081013

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.